ClinicalTrials.gov
public full text
Public Domain
A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma
The purpose of this study is to find out whether combining the study drugs rucaparib and nivolumab may be an effective treatment for advanced and/or metastatic LMS, and whether the study treatment works as well as the standard chemotherapy for this type of cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy#918722
- Study of Ruxolitinib in Colorectal Cancer Patients#1073684
- Rucaparib in Nonmetastatic prOstAte With BRCAness#979297
- A Study of Rucaparib in Japanese Patients With a Previously-treated Solid Tumor#994975
- Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma#967007
Record · ID 847532
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive